Tuesday 27 October 2015, Amsterdam
The report, now available on ASDReports, recognizes the following companies as the key players in the Global HIV Drugs Market: Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, and Merck.
Other Prominent Vendors in the market are: AbbVie, AstraZeneca, Boehringer Ingelheim, Cipla, Daiichi Sankyo, Emcure, F. Hoffmann-La Roche, Hetero Drugs, Mylan, Pfizer, Shionogi, and Teva Pharmaceutical Industries.
Commenting on the report, an analyst said: “Strategic alliances formed between companies, in terms of licensing and collaboration, is a key market trend that is helping co-development and commercialization of drugs in different regions.”
According to the report, unmet medical needs in the market present significant growth opportunities for vendors.
Further, the report states that adverse effects such as hepatotoxicity, hyperglycemia, hyperlipidemia, lactic acidosis, lipodystrophy, osteonecrosis, osteopenia, osteoporosis, and skin rash presents a significant challenge to this market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
ASDReports.com contact: S. Koomen
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216
back to News
